Efficacy of Sitagliptin added to sulfonylurea in subjects with poorly controlled type 2 diabetes (STRICT-1).
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Sitagliptin (Primary) ; Alpha-glucosidase inhibitors
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms STRICT-1
- 07 Mar 2018 Status changed from active, no longer recruiting to completed.
- 18 Apr 2013 Planned end date changed from 1 Sep 2013 to 30 Nov 2013 as reported by University Hospital Medical Information Network - Japan.
- 03 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.